Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
about
Proteomic Investigations into Hemodialysis TherapyReciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisOxidative stress and glutathione in TGF-beta-mediated fibrogenesisHuman body fluid proteome analysis.Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat.Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.Differences in the BAL proteome after Klebsiella pneumoniae infection in wild type and SP-A-/- mice.Preliminary characterizations of a serum biomarker for sarcoidosis by comparative proteomic approach with tandem-mass spectrometry in ethnic Han Chinese patients.An alternative view of the proposed alternative activities of hemopexin.Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.Expression profiling in granulomatous lung disease.Role of proteomics in the investigation of pulmonary fibrosis.Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosisAntioxidants as potential therapeutics for lung fibrosis.Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease.Chronic lung diseases.Proteome analysis of biological fluids from autoimmune-rheumatological disorders.A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls.Proteomic approaches for studying human parenchymal lung diseases.Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin.Cellular and molecular mechanisms of intestinal fibrosis.Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis.Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients.Astaxanthin supplementation attenuates immobilization-induced skeletal muscle fibrosis via suppression of oxidative stress.Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis.Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.Oxidized proteins in plasma of patients with heart failure: Role in endothelial damage
P2860
Q26774276-8D354D70-361B-4A2C-9900-2189263AB72FQ26779846-9FF342CA-0C2A-44D7-85ED-3CD8E11AF7BEQ28393454-7B0D56BB-D639-4BF9-8428-9EF9DB0BAFF7Q33262623-EACE8BFA-4B2D-48F6-B227-5D98D3192EC0Q33377867-2174CAB2-CAF6-4628-BA9A-5476B115CB26Q33754678-6BF1FA58-4E7D-4FF4-A272-E35AAB3D3D38Q34025684-381AD8F1-B9D5-412F-820A-88B0A594B702Q34582445-907259FD-46F9-4339-9E33-4A2761154AEAQ34627609-E7362F7C-1BCC-4326-B319-00EEE32D0CE9Q36084958-BAD78E73-61B2-423D-B10E-F3B7609C9C14Q36698837-9DF1037C-72CF-4E2F-BF52-C7180FAAADA5Q36841880-549387EB-C67B-4433-94B2-FD72E5ABCC54Q36940906-950A1ED0-17BE-489A-9A80-BF149DC66BA9Q36999926-8641234C-38A2-4596-811A-908777193719Q37110889-174E5C09-2F56-43AF-8B0A-2EB41E54BB9EQ37787966-0DB796AD-47A3-49DA-9125-905029EB2A2BQ37830007-405C8DDA-A705-4AF1-A514-543C27296F5EQ38473170-2FE0DFFD-F3A9-4747-A1C6-668914F19545Q39927233-8C6ED802-2870-4162-8363-292335290781Q40077740-1D890CCC-95DE-4F4E-B274-74DA630840C1Q42252132-1A4D2BD3-50F8-4205-B0C6-3ED76DF2CBB0Q44093570-9023F1D0-9365-4B9B-AEE1-22A31E1EE397Q46190109-B0D1FD2E-577E-4100-A608-6056956A508AQ46480706-89D232D7-484D-4C3E-94BB-7C00C4E017AFQ46934492-2DDC39A5-5FFE-4364-A43B-47B26A39ACA5Q53470982-5EF3303D-F88F-423E-8423-5F1F01EF3199Q55365053-1D004382-1D29-4FAD-9275-68264E538BC7Q57398777-BF5CF1CB-FD8D-4F6C-A6C4-6018C1DC4C52
P2860
Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@en
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@nl
type
label
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@en
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@nl
prefLabel
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@en
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@nl
P2093
P50
P356
P1433
P1476
Carbonylated proteins in bronc ...... idiopathic pulmonary fibrosis.
@en
P2093
Barbara Magi
Cecilia Vagaggini
Nikolaos Nikiforakis
Riccardo Cianti
Vitaliano Pallini
P304
P356
10.1002/PMIC.200401206
P577
2005-07-01T00:00:00Z